Dr. Priyom Bose

Dr. Priyom Bose

Feature Writer

B.Sc. Botany, M.Sc. Plant Biology and Biotechnology, Ph.D. Plant Biology and Biotechnology

Priyom holds a Ph.D. in Plant Biology and Biotechnology from the University of Madras, India. She is an active researcher and an experienced science writer. Priyom has also co-authored several original research articles that have been published in reputed peer-reviewed journals. She is also an avid reader and an amateur photographer.

Articles from Priyom

Researchers discover camelid-derived two nanobodies that target SARS-CoV-2

Researchers discover camelid-derived two nanobodies that target SARS-CoV-2

Researchers use mass spectrometry to study immunogenic SARS-CoV-2 epitopes

Researchers use mass spectrometry to study immunogenic SARS-CoV-2 epitopes

First dose of Pfizer-BioNTech or Oxford-AstraZeneca vaccines has strong protective effect against COVID-19 in older adults

First dose of Pfizer-BioNTech or Oxford-AstraZeneca vaccines has strong protective effect against COVID-19 in older adults

Efficacy of mRNA vaccine-induced memory B cells against SARS-CoV-2 variants

Efficacy of mRNA vaccine-induced memory B cells against SARS-CoV-2 variants

SARS-CoV-2 proteins manipulate autophagy

SARS-CoV-2 proteins manipulate autophagy

SARS-CoV-2 genomic surveillance identifies intricacies of stabilizing vs. destabilizing mutations

SARS-CoV-2 genomic surveillance identifies intricacies of stabilizing vs. destabilizing mutations

Researchers examine the effectiveness of the Pfizer-BioNTech COVID-19 vaccine in reducing household transmission

Researchers examine the effectiveness of the Pfizer-BioNTech COVID-19 vaccine in reducing household transmission

Study examines clinical outcomes in vaccinated individuals hospitalized with SARS-CoV-2 Delta variant

Study examines clinical outcomes in vaccinated individuals hospitalized with SARS-CoV-2 Delta variant

Thai study looks at CoronaVac vaccine vs. natural immunity to SARS-COV-2 variants

Thai study looks at CoronaVac vaccine vs. natural immunity to SARS-COV-2 variants

Stronger and longer SARS-CoV-2 RBD-ACE2 binding associated with glycans in new study

Stronger and longer SARS-CoV-2 RBD-ACE2 binding associated with glycans in new study